141 related articles for article (PubMed ID: 33097176)
1. Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Kumawat D; Samanta R; Sahay P
Am J Ophthalmol; 2020 Dec; 220():216-217. PubMed ID: 33097176
[No Abstract] [Full Text] [Related]
2. Reply to Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Fernandes Felix JP; Cavalcanti Lira RP; Grupenmacher AT; de Assis Filho HLG; Cosimo AB; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2020 Dec; 220():217-218. PubMed ID: 33097174
[No Abstract] [Full Text] [Related]
3. Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Fernandes Felix JP; Cavalcanti Lira RP; Grupenmacher AT; Assis Filho HLG; Cosimo AB; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2020 May; 213():195-202. PubMed ID: 31926883
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial.
Felix JP; Lira RP; Zacchia RS; Toribio JM; Nascimento MA; Arieta CE
Am J Ophthalmol; 2014 Apr; 157(4):762-766.e1. PubMed ID: 24388839
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
[TBL] [Abstract][Full Text] [Related]
6. Post-prophylaxis Toxoplasma chorioretinitis following donor-recipient mismatched liver transplantation.
Webb GJ; Shah H; David MD; Tiew S; Beare N; Hirschfield GM
Transpl Infect Dis; 2016 Oct; 18(5):805-808. PubMed ID: 27500398
[TBL] [Abstract][Full Text] [Related]
7. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.
Silveira C; Belfort R; Muccioli C; Holland GN; Victora CG; Horta BL; Yu F; Nussenblatt RB
Am J Ophthalmol; 2002 Jul; 134(1):41-6. PubMed ID: 12095806
[TBL] [Abstract][Full Text] [Related]
8. The role of intravitreal trimethoprim/sulfamethoxazole in the treatment of toxoplasma retinochoroiditis.
Choudhury H; Jindal A; Pathengay A; Bawdekar A; Albini T; Flynn HW
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):137-40. PubMed ID: 25559528
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.
Opremcak EM; Scales DK; Sharpe MR
Ophthalmology; 1992 Jun; 99(6):920-5. PubMed ID: 1630782
[TBL] [Abstract][Full Text] [Related]
10. False Negative Toxoplasma Serology in an Immunocompromised Patient with PCR Positive Ocular Toxoplasmosis.
Rajput R; Denniston AK; Murray PI
Ocul Immunol Inflamm; 2018; 26(8):1200-1202. PubMed ID: 28700250
[TBL] [Abstract][Full Text] [Related]
11. [Bilateral toxoplasma retinochoroiditis secondary to primary infection in an immunocompetent patient].
Rémond AL; Diwo E; Zarrouk V; Bodaghi B
J Fr Ophtalmol; 2018 Oct; 41(8):e361-e366. PubMed ID: 30253870
[No Abstract] [Full Text] [Related]
12. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
[TBL] [Abstract][Full Text] [Related]
13. Ophthaproblem. Can you identify this condition? Toxoplasma retinochoroiditis.
Moreno-Martin P; Vallejo-Garcia JL; Rayward O; Vano-Galvan S
Can Fam Physician; 2011 Dec; 57(12):1415, 1419. PubMed ID: 22170198
[No Abstract] [Full Text] [Related]
14. Ocular toxoplasmosis: toxoplasmic retinochoroiditis.
Tabbara KF
Int Ophthalmol Clin; 1995; 35(2):15-29. PubMed ID: 7490177
[No Abstract] [Full Text] [Related]
15. Bilateral toxoplasma retinochoroiditis simulating cytomegalovirus retinitis in an allogeneic bone marrow transplant patient.
Chung H; Kim JG; Choi SH; Lee SY; Yoon YH
Korean J Ophthalmol; 2008 Sep; 22(3):197-200. PubMed ID: 18784451
[TBL] [Abstract][Full Text] [Related]
16. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.
Holland GN
Am J Ophthalmol; 2004 Jan; 137(1):1-17. PubMed ID: 14700638
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
18. Atypical toxoplasmic retinochoroiditis.
Theodoropoulou S; Schmoll C; Templeton K; Dhillon B
BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669878
[TBL] [Abstract][Full Text] [Related]
19. Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate.
Basu S; Das T; Biswas G
Ocul Immunol Inflamm; 2010 Jan; 18(1):64-5. PubMed ID: 20128654
[TBL] [Abstract][Full Text] [Related]
20. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
Lebech AM; Lebech M; Børme KK; Mathiesen LR
Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
